Research Article
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry
Table 3
Patients with [Na+] ≥5 mmol/L in response to initial and secondary .
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
with initial moderate or severe hyponatremia. Initial therapy P <0.05 for Day 2 response: no specific therapy (NST) vs hypertonic saline (HS), and fluid restriction (FR) vs HS and isotonic saline (NS); Day 3 response: NST vs HS and tolvaptan (TO); FR vs HS, NS, and TO: final response: NST vs TO, FR vs HS and TO, and NS vs TO. |